Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: A cross-sectional study on burden

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Zonneveld, Lyonne Nl ^a,b,c   Sprangers, Mirjam Ag ^c   Kooiman, Cornelis G ^d   Van'T Spijker, Adriaan ^a   Busschbach, Jan Jv ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Department of Psychotherapy Riagg Rijnmond ^*  (Netherlands)

Author keywords

Absenteeism; Burden; Chronic disease; Costs; Healthcare utilization; Presenteeism; Production loss; Quality of life; Somatic symptom disorder; Somatoform disorder; Unexplained physical symptoms

Indexed keywords

ABSENTEEISM; ARTICLE; COST OF ILLNESS; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MALE; MIDDLE AGED; NETHERLANDS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SOMATOFORM DISORDER; STATISTICS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ABSENTEEISM; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; SOMATOFORM DISORDERS;

EID: 84890282229     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-520     Document Type: Article

References (70)

1. Patients presenting with somatic complaints: epidemiology, psychiatric co-morbidity and management. Kroenke K, Int J Methods Psychiatr Res 2003 12 1 34 43 (Pubitemid 36675446)
2. Medically unexplained symptoms: an epidemiological study in seven specialities. Nimnuan C, Hotopf M, Wessely S, J Psychosom Res 2001 51 1 361 367 (Pubitemid 32700445)
3. Is alexithymia a risk factor for unexplained physical symptoms in general medical outpatients? Kooiman CG, Bolk JH, Brand R, Trijsburg RW, Rooijmans HG, Psychosom Med 2000 62 6 768 778 (Pubitemid 32009082)
4. The burden of mental disorders in primary care. Grandes G, Montoya I, Arietaleanizbeaskoa MS, Arce V, Sanchez A, European Psychiatry 2011 26 7 428 435
5. Demographic characteristics and quality of life of patients with unexplained complaints: a descriptive study in general practice. Koch H, Van Bokhoven MA, Ter Riet G, Van der Weijden T, Dinant GJ, Bindels PJE, Qual Life Res 2007 16 9 1483 1489 (Pubitemid 47561726)
6. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Löwe B, Spitzer RL, Williams JBW, Mussell M, Schellberg D, Kroenke K, Gen Hosp Psychiatry 2008 30 3 191 199 (Pubitemid 351538962)
7. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. De Waal MWM, Arnold IA, Eekhof JAH, Van Hemert AM, Br J Psychiatry 2004 184 6 470 476 (Pubitemid 38725705)
8. Persistent presentation of medically unexplained symptoms in general practice. Verhaak PFM, Meijer SA, Visser AP, Wolters G, Fam Pract 2006 23 4 414 420
9. Patients with multiple unexplained symptoms: their characteristics, functional health, and health care utilization. Smith GR, Monson RA, Ray DC, Arch Intern Med 1986 146 1 69 72 (Pubitemid 16158631)
10. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Barsky AJ, Orav EJ, Bates DW, Arch Gen Psychiatry 2005 62 8 903 910 (Pubitemid 41126885)
11. The economic impact of chronic fatigue syndrome. Reynolds KJ, Vernon SD, Bouchery E, Reeves WC, Cost Effectiveness and Resource Allocation 2004 2 1 4
12. Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall. Stolk EA, Van Donselaar G, Brouwer WBF, Busschbach JJV, Pharmacoeconomics 2004 22 17 1097 1107 (Pubitemid 39665341)
13. Equity in health care prioritisation: an empirical inquiry into social value. Stolk EA, Pickee SJ, Ament AHJA, Busschbach JJV, Health Policy 2005 74 3 343 355 (Pubitemid 41446140)
14. Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. Busschbach JJV, McDonnell J, Essink-Bot M-L, Van Hout BA, J Health Econ 1999 18 5 551 571
15. A comparison of the EQ-5D and SF-6D across seven patient groups. Brazier J, Roberts J, Tsuchiya A, Busschbach J, Health Econ 2004 13 9 873 884 (Pubitemid 39264234)
16. Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Moock J, Kohlmann T, Qual Life Res 2008 17 3 485 495
17. Acupuncture for 'frequent attenders' with medically unexplained symptoms: a randomised controlled trial (CACTUS study). Paterson C, Taylor RS, Griffiths P, Britten N, Rugg S, Bridges J, McCallum B, Kite G, Br J Gen Pract 2011 61 587 295 e305
18. Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up. Zonneveld LNL, Van Rood YR, Timman R, Kooiman CG, Van 't Spijker A, Busschbach JJV, PLoS ONE 2012 7 8 42629
19. The effectiveness of a training for patients with unexplained physical symptoms: protocol of a cognitive behavioral group training and randomized controlled trial. Zonneveld LNL, Van't Spijker A, Passchier J, Van Busschbach JJ, Duivenvoorden HJ, BMC Public Health 2009 9 251
20. First MB, Spitzer RL, Gibbon M, Williams JBW, Structured clinical interview for DSM-IV axis I disorders Amsterdam: Harcourt Test Publishers 1999
21. Ware JE, Snow KK, Kosinski M, Gandek B, SF-36 health survey: manual and interpretation guide Boston, MA: New England Medical Center, The Health Institute 1993
22. Translation, validation and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. Aaronson NK, Muller M, Cohen PDA, Essink-Bot M, Fekkes M, Sanderman R, Sprangers MAG, Te Velde AM, Verrips E, J Clin Epidemiol 1998 51 11 1055 1068 (Pubitemid 28527161)
23. The estimation of a preference-based measure of health from the SF-36. Brazier J, Roberts J, Deverill M, J Health Econ 2002 21 2 271 292 (Pubitemid 34143147)
24. Handleiding Trimbos/iMTA questionnaire for costs associated with psychiatric Illness (TiC-P). Hakkaart-van Roijen L, juli 2002 edn Rotterdam: Institute for Medical Technology Assessment & Erasmus Universiteit Rotterdam 2002
25. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM, Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg, Geactualiseerde versie 2010 edn Diemen: College voor Zorgverzekeringen 2010
26. Hakkaart-van Roijen L, Van Straten A, Donker M, Tiemens B, Handleiding Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TiC-P) Rotterdam: Instituut voor Medische Technology Assessment, Erasmus Universiteit Rotterdam 2010
27. Group training for patients with unexplained physical symptoms. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1609
28. Consumentenprijzen; prijsindex 2006 = 100 (CPI 2009). Statistics N, vol. 2012 Den Haag/Heerlen: Statistics Netherlands/Centraal Bureau voor de Statistiek 2012
29. Consumentenprijzen; prijsindex 2006 = 100 (CPI 2007). Statistics N, vol. 2012 Den Haag/Heerlen: Statistics Netherlands/Centraal Bureau voor de Statistiek 2012
30. Productivity losses without absence: measurement validation and empirical evidence. Brouwer WBF, Koopmanschap MA, Rutten FFH, Health Policy 1999 48 1 13 27 (Pubitemid 29295395)
31. Statistics N, Cao-lonen, contractuele loonkosten en arbeidsduur; indexcijfers (2000 = 100). In., vol. 2012 Den Haag/Heerlen: Statistics Netherlands/Centraal Bureau voor de Statistiek 2012
32. Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Smith RC, Gardiner JC, Lyles JS, Sirbu C, Dwamena FC, Hodges A, Collins C, Lein C, Given CW, Given B, et al. Psychosom Med 2005 67 1 123 129
33. Levels of disability in major depression: findings from the Netherlands mental health survey and incidence study (NEMESIS). Kruijshaar ME, Hoeymans N, Bijl RV, Spijker J, Essink-Bot ML, J Affect Disord 2003 77 1 53 64 (Pubitemid 37205151)
34. Interpreting the meaningfulness of changes in health-related quality of life scores: lessons from studies in adults. Osoba D, Int J Cancer 1999 83 S12 132 137
35. Measurement of health status: ascertaining the minimal clinically important difference. Jaeschke R, Singer J, Guyatt GH, Control Clin Trials 1989 10 4 407 415 (Pubitemid 20025670)
36. Comparing SF-6D and EQ-5D utilities across groups differing in health status. Kontodimopoulos N, Pappa E, Papadopoulos AA, Tountas Y, Niakas D, Qual Life Res 2009 18 1 87 97
37. Burden of chronic physical conditions and mental disorders in primary care. Fernández A, Saameño JÁB, Pinto-Meza A, Luciano JV, Autonell J, Palao D, Salvador-Carulla L, Campayo JG, Haro JM, Serrano A, Br J Psychiatry 2010 196 4 302 309
38. The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities. Teckle P, Peacock S, McTaggart-Cowan H, Van der Hoek K, Chia S, Melosky B, Gelmon K, Health Qual Life Outcomes 2011 9 106
39. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. Kontodimopoulos N, Aletras VH, Paliouras D, Niakas D, Value in Health 2009 12 8 1151 1157
40. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Walters SJ, Brazier JE, Qual Life Res 2005 14 6 1523 1532 (Pubitemid 40848233)
41. Kosten van ziekten in Nederland 2007: trends in de Nederlandse zorguitgaven 1999-2010. Slobbe LCJ, Smit JM, Groen J, Poos MJJC, Kommer GJ, Zorg voor euro's Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu (RIVM)/Centraal Bureau voor de Statistiek (CBS) 2011 RIVM-rapportnummer 270751023/270752011
42. Klein Hesselink J, Hooftman W, Koppes L, Ziekteverzuim in Nederland in 2010 Hoofddorp: TNO 2012
43. The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, Ten Have M, Nolen WA, Veraart CPWM, Rutten FFH, Acta Psychiatr Scand 2004 110 5 383 392 (Pubitemid 39424840)
44. The economic burden of personality disorders in mental health care. Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJV, J Clin Psychiatry 2008 69 2 259 265 (Pubitemid 351469269)
45. Gr J-G, Beperkt aan het werk: rapportage ziekteverzuim, arbeidsongeschiktheid en arbeidsparticipatie Den Haag: Sociaal en Cultureel Planbureau 2010
46. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA. Braakman-Jansen LMA, Taal E, Kuper IH, Van de Laar MAFJ, Rheumatology (Oxford) 2012 51 2 354 361
47. Costs of nine common mental disorders: implications for curative and preventive psychiatry. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, De Graaf R, Beekman A, J Ment Health Policy Econ 2006 9 4 193 200 (Pubitemid 46138516)
48. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Kroenke K, Psychosom Med 2007 69 9 881 888 (Pubitemid 350158831)
49. Personality dysfunction among somatizing patients. Noyes R, Langbehn DR, Happel RL, Stout LR, Muller BA, Longley SL, Psychosomatics 2001 42 4 320 329 (Pubitemid 32692105)
50. Somatoform disorders: comorbidity with other DSM-III-R psychiatric diagnoses in Greece. Garyfallos G, Adamopoulou A, Karastergiou A, Voikli M, Ikonomidis N, Donias S, Giouzepas J, Dimitriou E, Compr Psychiatry 1999 40 4 299 307 (Pubitemid 29319245)
51. Effect of comorbid anxiety, depressive, and personality disorders on treatment outcome of somatoform disorders. Leibbrand R, Hiller W, Fichter MM, Compr Psychiatry 1999 40 3 203 209 (Pubitemid 29237311)
52. Part II: a prospective DSM-III study of 100 consecutive somatization patients. Katon WJ, Ries RK, Kleinman A, Compr Psychiatry 1984 25 3 305 314
53. Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria. Uguz F, Engin B, Yilmaz E, J Psychosom Res 2008 64 2 225 229
54. Personality disorders in somatization disorder patients: a controlled study in Spain. Garcia-Campayo J, Alda M, Sobradiel N, Olivan B, Pascual A, J Psychosom Res 2007 62 6 675 680 (Pubitemid 46809917)
55. Personality disorders in patients with burning mouth syndrome. Maina G, Albert U, Gandolfo S, Vitalucci A, Bogetto F, J Personal Disord 2005 19 1 84 93 (Pubitemid 40397365)
56. Objective assessment of personality disorder in chronic fatigue syndrome. Henderson M, Tannock C, J Psychosom Res 2004 56 2 251 254 (Pubitemid 38317479)
57. Personality profiles in patients referred for chest pain: investigation with emphasis on panic disorder patients. Dammen T, Ekeberg Ø Arnesen H, Friis S, Psychosomatics 2000 41 3 269 276 (Pubitemid 30331941)
58. The comorbidity of DSM-III-R personality disorders in somatization disorder. Rost KM, Akins RN, Brown FW, Smith GR, Gen Hosp Psychiatry 1992 14 5 322 326
59. Which chronic conditions are associated with better or poorer quality of life? Sprangers MAG, De Regt EB, Andries F, Van Agt HME, Bijl RV, De Boer JB, Foets M, Hoeymans N, Jacobs AE, Kempen GIJM, et al. J Clin Epidemiol 2000 53 9 895 907
60. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Henningsen P, Zimmermann T, Sattel H, Psychosom Med 2003 65 4 528 533 (Pubitemid 36900246)
61. Health and work productivity assessment: state of the art or state of flux? Evans CJ, J Occup Environ Med 2004 46 6 3 S11
62. Healthcare resource and lost labor costs of migraine headache in the US. Osterhaus JT, Gutterman DL, Plachetka JR, Pharmacoeconomics 1992 2 1 67 76
63. Cognitive-behavior therapy for medically unexplained symptoms: a critical review of the treatment literature. Nezu AM, Nezu CM, Lombardo ER, Behavior Therapy 2001 32 3 537 583 (Pubitemid 33001006)
64. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Sumathipala A, Psychosom Med 2007 69 9 889 900 (Pubitemid 350161711)
65. Cognitive behavioural therapy v. structured care for medically unexplained symptoms: randomised controlled trial. Sumathipala A, Siribaddana S, Abeysingha MRN, De Silva P, Dewey M, Prince M, Mann AH, Br J Psychiatry 2008 193 1 51 59 (Pubitemid 351946808)
66. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Morriss R, Dowrick C, Salmon P, Peters S, Dunn G, Rogers A, Lewis B, Charles-Jones H, Hogg J, Clifford R, et al. Br J Psychiatry 2007 191 6 536 542 (Pubitemid 350273215)
67. A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Aiarzaguena JM, Grandes G, Gaminde I, Salazar A, Sánchez Á Ariño J, Psychol Med 2007 37 2 283 294 (Pubitemid 46158169)
68. Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial (the Functional Illness in Primary Care Study). Toft T, Rosendal M, Ørnbøl E, Olesen F, Frostholm L, Fink P, Psychother Psychosom 2010 79 4 227 237
69. Medically unexplained physical symptoms in primary care: a controlled study on the effectiveness of cognitive-behavioral treatment by the family physician. Arnold IA, De Waal MWM, Eekhof JAH, Assendelft WJJ, Spinhoven P, Van Hemert AM, Psychosomatics 2009 50 5 515 524
70. A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. Rosendal M, Olesen F, Fink P, Toft T, Sokolowski I, Bro F, Gen Hosp Psychiatry 2007 29 4 364 373 (Pubitemid 46962691)